The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1876-6250
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The WOEST 2 registry ; volume:30 ; number:6 ; day:1 ; month:3 ; year:2022 ; pages:302-311 ; date:6.2022
Netherlands heart journal ; 30, Heft 6 (1.3.2022), 302-311, 6.2022
- Creator
-
Veer, A. J. W. M. de
Bennaghmouch, N.
Bor, W. L.
Herrman, J. P. R.
Vrolix, M.
Meuwissen, M.
Vandendriessche, T.
Adriaenssens, T.
Bruyne, B. de
Magro, M.
Dewilde, W. J. M.
Berg, J. M. ten
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12471-022-01664-0
- URN
-
urn:nbn:de:101:1-2022072221495758207011
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Veer, A. J. W. M. de
- Bennaghmouch, N.
- Bor, W. L.
- Herrman, J. P. R.
- Vrolix, M.
- Meuwissen, M.
- Vandendriessche, T.
- Adriaenssens, T.
- Bruyne, B. de
- Magro, M.
- Dewilde, W. J. M.
- Berg, J. M. ten
- SpringerLink (Online service)
Other Objects (12)
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
Rationale and design of the Chinese Atrial Fibrillation Registry Study
Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study
Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China
Gastrointestinal bleeding in elderly patients with atrial fibrillation: prespecified All Nippon Atrial Fibrillation in the Elderly (ANAFIE) Registry subgroup analysis
Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
Catheter ablation of atrial fibrillation in Korea: results from the Korean Heart Rhythm Society Ablation Registry for Atrial Fibrillation (KARA)
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
Rationale and design of the Chinese Atrial Fibrillation Registry Study
Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study
Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China
Gastrointestinal bleeding in elderly patients with atrial fibrillation: prespecified All Nippon Atrial Fibrillation in the Elderly (ANAFIE) Registry subgroup analysis
Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
Catheter ablation of atrial fibrillation in Korea: results from the Korean Heart Rhythm Society Ablation Registry for Atrial Fibrillation (KARA)
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Regional Differences in Antithrombotic Treatment for Atrial Fibrillation: Insights from the GLORIA-AF Phase II Registry
Rationale and design of the Chinese Atrial Fibrillation Registry Study
Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study
Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry : Trends in antithrombotic therapy use in China
Gastrointestinal bleeding in elderly patients with atrial fibrillation: prespecified All Nippon Atrial Fibrillation in the Elderly (ANAFIE) Registry subgroup analysis
Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
Catheter ablation of atrial fibrillation in Korea: results from the Korean Heart Rhythm Society Ablation Registry for Atrial Fibrillation (KARA)
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI